Vanda Pharmaceuticals Stock Analysis

Vanda Stock Analysis Notes

About 77.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.52. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vanda Pharmaceuticals recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. Vanda Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 278 people. For more information please call the company at 202 734 3400 or visit https://www.vandapharma.com.

Vanda Pharmaceuticals Investment Alerts

Vanda Pharmaceuticals Upcoming and Recent Events

Vanda Largest EPS Surprises

View All Earnings Estimates

Vanda Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Vanda Stock Institutional Investors

Note, although Vanda Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vanda Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 314.86 M.

Vanda Profitablity

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.23.

Management Efficiency

Vanda Pharmaceuticals has return on total asset (ROA) of (0.0364) % which means that it has lost $0.0364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0302) %, meaning that it created substantial loss on money invested by shareholders. Vanda Pharmaceuticals' management efficiency ratios could be used to measure how well Vanda Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.04. In addition to that, Return On Capital Employed is expected to decline to -0.08. At present, Vanda Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 228.2 M, whereas Other Current Assets are forecasted to decline to about 7.9 M.

Technical Drivers

As of the 25th of March, Vanda Pharmaceuticals has the Semi Deviation of 2.33, coefficient of variation of 2735.94, and Risk Adjusted Performance of 0.0394. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vanda Pharmaceuticals, as well as the relationship between them.

Vanda Pharmaceuticals Price Movement Analysis

Vanda Pharmaceuticals Insider Trading Activities

Vanda Pharmaceuticals Outstanding Bonds

Vanda Pharmaceuticals Predictive Daily Indicators

Vanda Pharmaceuticals Forecast Models

Vanda Pharmaceuticals' time-series forecasting models are one of many Vanda Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vanda Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vanda Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vanda shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vanda Pharmaceuticals. By using and applying Vanda Stock analysis, traders can create a robust methodology for identifying Vanda entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vanda analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vanda analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Vanda Pharmaceuticals stock analysis indicators help investors evaluate how Vanda Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vanda Pharmaceuticals shares will generate the highest return on investment. By understating and applying Vanda Pharmaceuticals stock analysis, traders can identify Vanda Pharmaceuticals position entry and exit signals to maximize returns.

When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.